719TiP A phase I/Ib study of the Werner (WRN) helicase inhibitor HRO761 as single agent and in combination with irinotecan or tislelizumab in patients with microsatellite instability-high (MSIhi) or mismatch repair deficient (dMMR) advanced solid tumors
| Autor: | Moschetta, M., Doi, T., Kuboki, Y., Sundar, R., Möbitz, H., Jaco, I., Cortes Cros, M., Ferretti, S., Jankovic, D., Thérier, M., Clementi, G., Li, Y., De Kanter, R., Quadt, C. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S496-S496 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|